Gastric Infection Therapy
Project Overview
Year
About
This research explores a novel immunotherapy for Helicobacter pylori, a bacterium linked to ulcers and gastric cancer. Instead of antibiotics, it uses antibodies from immunised hens to block a protein essential for the bacterium’s survival. In lab tests, these antibodies cut the activity of urease, an enzyme H. pylori uses to neutralize stomach acid, by more than 84%, and inhibit bacterial growth. The approach shows promise as a safer, resistance-free alternative to antibiotics, potentially offering new hope for millions affected by this widespread infection
Team
Shaho Menbari
Sara Kamal Shahsavar
Mashhad University of Medical Sciences
Sara is a researcher with a Master of Science in Medical Microbiology from Mashhad University of Medical Sciences, Iran. Her thesis explored the inhibitory potential of IgY antibodies in the treatment and prophylaxis of Helicobacter pylori infection. Sara's academic journey began when she earned her Bachelor of Science in Cellular and Molecular Biology. Her research interests span the development of novel biomedical applications of natural compounds, with a focus on the therapeutic potentials of antibodies. Her research interests include Gene expression, Recombinant Protein Expression and Purification, and Plasmid Cloning."
Nima Hajinajaf
Zahra Esmaeili
Hamid Ariannejad
Gallery
